Near East University announced that only one person among 609 healthcare staff who received the Sinovac vaccine in the last 6 months had COVID-19.

Also available in: Türkçe

Added On: 22 July 2021, Thursday, 09:36
Last Edited On: 26 July 2021, Monday, 10:54

Near East University announced that only one person among 609 healthcare staff who received the Sinovac vaccine in the last 6 months had COVID-19.

Continuing scientific studies to determine the effects of the COVID-19 vaccine on the course of the pandemic, Near East University announced the six-month results of the research focusing on detecting spike antibody levels that developed after the vaccine. According to the results, only one of 609 healthcare staff who received the Sinovac vaccine suffered from COVID-19 after a double dose of vaccination. The patient, who was recorded as a case caused by family transmission, had a mild COVID-19 process. There were no other patients for 6 months among the 609 healthcare staff who were followed up. The results were interpreted as the high level of protection of the Sinovac vaccine.

Near East University announced that only one person among 609 healthcare staff who received the Sinovac vaccine in the last 6 months had COVID-19.
Prof. Dr. Tamer Şanlıdağ: “The fact that only 1 person out of 609 healthcare staff who have the Sinovac vaccine has COVID-19 due to family transmission is important in terms of demonstrating the effectiveness of the vaccine.”
Stating that with this research project, they followed the development of antibodies and infections in people who had the Sinovac’s Coronavac COVID-19 vaccine, Near East University Acting Rector Prof. Dr. Tamer Şanlıdağ said that they obtained important scientific findings as a result of the studies they carried out within the scope of the project. Emphasizing that according to the results, they determined that the applied COVID-19 vaccines provide high antibody production in both women and men, Prof. Dr. Şanlıdağ also commented on the findings as follows; “The presence of only one COVID-19 case among 609 healthcare workers who received the second dose of the vaccine and the high level of antibodies are important findings showing the effectiveness of the vaccine.”